Evidence map›Paper›PMID 39766553›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Accelerated Bacterial Identification with MALDI-TOF MS Leads to Fewer Diagnostic Tests and Cost Savings.

Miriam Uzuriaga, Francisco Guillén-Grima, Marta Rua, José Leiva, José R Yuste

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miriam UzuriagaClinical Microbiology Service, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-0174-9094
Francisco Guillén-GrimaHealthcare Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0001-9749-8076
Marta RuaClinical Microbiology Service, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-4727-0660
José LeivaClinical Microbiology Service, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-8380-3161
José R YusteHealthcare Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0001-8502-9539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRapid microbiology reporting can enhance both clinical and economic outcomes. MATERIAL AND

methodsThis three-year, quasi-experimental study, single-group pretest-posttest study, conducted at a university medical center, aimed to evaluate the clinical and economic impact of rapid microbiological identification reporting using MALDI-TOF MS. A total of 363 consecutive hospitalized patients with bacterial infections were evaluated, comparing a historical control group (CG, n = 183) with an intervention group (IG,

resultsThe IG demonstrated a significant reduction in the number of patients undergoing Microbiology (

Indexed as

clinical impactcostsdiagnosticseconomic impactfast informationMALDI-TOF MS

Identifiers

PMID39766553
PMCPMC11672624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.